CTXR
Citius Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $26.37M | Price | $1.58 |
| Volume | 402.32K | Change | +0.64% |
| P/E Ratio | -0.7 | Open | $1.57 |
| Revenue | -- | Prev Close | $1.57 |
| Net Income | $-40.2M | 52W Range | $0.65 - $12.85 |
| Div Yield | N/A | Target | $6.00 |
| Overall | 48 | Value | 60 |
| Quality | 26 | Technical | 58 |
No chart data available
Stock Overview
Updated DailyCitius Pharmaceuticals Inc. (CTXR) is a leading Healthcare company in the Biotechnology industry, currently trading at $1.58 with a market capitalization of $26.37 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating concerning quality fundamentals with a MarketXLS quality score of 26.
Today's trading session shows CTXR with a volume of 402K shares. The stock opened down 0.00% from yesterday's close of $1.57. Current analyst estimates project earnings of $NA per share for this year, with next year targeting $NA.
CTXR demonstrates neutral technical outlook based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for CTXR include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 279.7%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 06:58 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CTXR | $1.58 | +0.6% | 402.32K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Citius Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW